p63 and p73 - Life and death in squamous cell carcinoma

被引:34
作者
Rocco, James W.
Ellisen, Leif W.
机构
[1] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Massachusetts Gen Hosp, Div Surg Oncol, Boston, MA 02114 USA
[4] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA
关键词
p63; p73; p53; squamous cell carcinoma; HNSCC; apoptosis; RNA interference; chemotherapy;
D O I
10.4161/cc.5.9.2716
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The p53 family member p63 plays an essential role in the developing epithelium, and overexpression of the Delta Np63 alpha isoform is frequently observed in human squamous cell carcinomas (SCCs). These findings have suggested that Delta Np63 alpha might function as an oncogene within squamous epithelial cells. Nevertheless, the mechanism by which Delta Np63 alpha might promote tumorigenesis remains poorly understood, and data from mouse models implies that the p63 locus might in fact function as a tumor suppressor in these same tissues. A recent study using RNA interference in human SCC-derived cell lines shows that Delta Np63 alpha mediates an essential survival function in human SCC cells by virtue of its ability to suppress the pro-apoptotic function of the related p53 family member p73. These findings support an oncogenic role for Delta Np63 alpha and they demonstrate the existence of critical physical and functional interactions between endogenous p53 family members in human cancer. Specific chemotherapeutic agents and future targeted approaches may be able to exploit this pathway to therapeutic advantage.
引用
收藏
页码:936 / 940
页数:5
相关论文
共 50 条
[1]   IGFBP-3 is a direct target of transcriptional regulation by ΔNp63α in squamous epithelium [J].
Barbieri, CE ;
Perez, CA ;
Johnson, KN ;
Ely, KA ;
Billheimer, D ;
Pietenpol, JA .
CANCER RESEARCH, 2005, 65 (06) :2314-2320
[2]   p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis [J].
Bergamaschi, D ;
Gasco, M ;
Hiller, L ;
Sullivan, A ;
Syed, N ;
Trigiante, G ;
Yulug, I ;
Merlano, M ;
Numico, G ;
Comino, A ;
Attard, M ;
Reelfs, O ;
Gusterson, B ;
Bell, AK ;
Heath, V ;
Tavassoli, M ;
Farrell, PJ ;
Smith, P ;
Lu, X ;
Crook, T .
CANCER CELL, 2003, 3 (04) :387-402
[3]  
Bjorkqvist AM, 1998, GENE CHROMOSOME CANC, V22, P79
[4]   How many mutant p53 molecules are needed to inactivate a tetramer? [J].
Chan, WM ;
Siu, WY ;
Lau, A ;
Poon, RYC .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (08) :3536-3551
[5]   Hypermethylation of gene promoters in hematological neoplasia [J].
Chim, CS ;
Liang, R ;
Kwong, YL .
HEMATOLOGICAL ONCOLOGY, 2002, 20 (04) :167-176
[6]   Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis [J].
Choi, HR ;
Batsakis, JG ;
Zhan, F ;
Sturgis, E ;
Luna, MA ;
El-Naggar, AK .
HUMAN PATHOLOGY, 2002, 33 (02) :158-164
[7]  
CUI R, 2005, BIOCH BIOPHYS RES CO
[8]   p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53 [J].
Davison, TS ;
Vagner, C ;
Kaghad, M ;
Ayed, A ;
Caput, D ;
Arrowsmith, CH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (26) :18709-18714
[9]   p63 and p73 transactivate differentiation gene promoters in human keratinocytes [J].
De Laurenzi, V ;
Rossi, A ;
Terrinoni, A ;
Barcaroli, D ;
Levrero, M ;
Costanzo, A ;
Knight, RA ;
Guerrieri, P ;
Melino, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 273 (01) :342-346
[10]   REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species [J].
Ellisen, LW ;
Ramsayer, KD ;
Johannessen, CM ;
Yang, A ;
Beppu, H ;
Minda, K ;
Oliner, JD ;
McKeon, F ;
Haber, DA .
MOLECULAR CELL, 2002, 10 (05) :995-1005